glp 1 drugs news Medicare is about to cover GLP-1 for weight loss. Here's what to know Periodic Graphics: The science of
Description
Diabetes Care 28 , 10921100 (2005)
Patent expiry in March 2026 invites further generics, potentially accelerating volume but pressuring branded margins within the Latin America GLP-1 agonists market
Obesity is preventable and reversible
Incretin hormones cause the body to produce insulin when eating sugar, called the incretin effect
Severe gastroparesis
